DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

The Westin Boston Waterfront

2016 年 08 月 15 日 7:30 上午 - 2016 年 08 月 18 日 5:00 下午

425 Summer Street, Boston, MA 02210

Regulatory Affairs: The IND, NDA, and Postmarketing

Session 26: Review of Prescription Drug/Biologics Advertising and Promotional Labeling

Session Chair(s)

Drusilla  Scott, PHD, RAC

Drusilla Scott, PHD, RAC

Vice President, Regulatory Affairs

Sobi, Inc., United States

Carol H. Danielson, DrPH, MS, RAC

Carol H. Danielson, DrPH, MS, RAC

President

Regulatory Advantage, LLC, United States

  • Definitions
  • Statutory Basis for Promotional Regulations
  • Required Elements for Advertisements and Promotional Labeling
  • Reminder Advertisements/Labeling
  • Preapproval Promotional Activities
  • Other Topics
  • FDA Enforcement Actions
  • Launch of Promotional Pieces
  • Postmarketing Submission of Advertising
  • Summary of Principles for Advertising and Promotion

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。